Cigna Group (NYSE:CI) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Cigna Group (NYSE:CI) from a hold rating to a buy rating in a report published on Saturday morning.

Several other equities research analysts have also commented on CI. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Cigna Group from $415.00 to $301.00 and set a “buy” rating on the stock in a report on Monday, November 3rd. Leerink Partners boosted their price objective on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday. Truist Financial upped their target price on Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a research note on Monday, January 5th. Robert W. Baird dropped their target price on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Finally, TD Cowen set a $333.00 price target on Cigna Group in a report on Monday, December 15th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average target price of $323.16.

Cigna Group Trading Up 2.7%

Cigna Group stock opened at $292.29 on Friday. The stock has a 50-day moving average price of $274.77 and a 200 day moving average price of $283.83. The company has a market capitalization of $78.08 billion, a price-to-earnings ratio of 13.18, a price-to-earnings-growth ratio of 1.04 and a beta of 0.27. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a quick ratio of 0.76, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, March 5th. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 26.64%.

Institutional Trading of Cigna Group

Several institutional investors have recently modified their holdings of CI. Brighton Jones LLC lifted its stake in Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares in the last quarter. Sivia Capital Partners LLC raised its holdings in shares of Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the last quarter. Venturi Wealth Management LLC lifted its position in shares of Cigna Group by 5.3% in the second quarter. Venturi Wealth Management LLC now owns 896 shares of the health services provider’s stock valued at $296,000 after acquiring an additional 45 shares in the last quarter. Clear Creek Financial Management LLC acquired a new stake in shares of Cigna Group in the second quarter worth approximately $250,000. Finally, Leo Wealth LLC acquired a new stake in shares of Cigna Group in the second quarter worth approximately $228,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q4 earnings and revenue beat — Cigna reported adjusted EPS of $8.08 and revenue of $72.5B, both above consensus, driven by Evernorth growth and higher specialty volumes; investors are rewarding the beat and evidence of durable revenue momentum. Cigna Q4 Highlights
• Positive Sentiment: FTC settlement over insulin pricing reduces regulatory overhang and includes commitments to change PBM pricing practices — this removes a major legal uncertainty and may support multiple expansion. FTC Settlement Coverage
• Positive Sentiment: Dividend increase — the board raised the quarterly dividend to $1.56 (3.3% increase), a modest buyback/dividend-friendly signal that supports income investors. Dividend Announcement
• Neutral Sentiment: Analyst price target moves are mixed — Leerink raised its PT to $297 but kept a “market perform” rating, while RBC trimmed its PT to $333 but maintained an “outperform” view; these moves show cautious optimism but limited near-term upside consensus. Leerink PT Change RBC PT Change
• Neutral Sentiment: Evernorth and specialty volumes are growth drivers cited on the call — supportive for revenue mix and long-term profit potential, though investors will watch margin dynamics. Evernorth Growth Coverage
• Negative Sentiment: 2026 guidance slightly below some Street expectations — Cigna set FY 2026 EPS guidance at at least $30.25, a touch under consensus and accompanied by commentary about ongoing medical-cost and margin pressure; this tempered the upside from the quarter for some investors. Guidance Miss Coverage

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.